Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.4050 (-4.75%) ($2.4050 - $2.4050) on Thu. Apr. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 22 | Latest Price | $2.4050(-4.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -3.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -11.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) SPY(99%) IVE(97%) IWF(97%) VUG(97%) IVW(96%) | Factors Impacting CGEN price | CGEN will decline at least -1.98% in a week (0% probabilities). UNG(-46%) UUP(-13%) TIP(-13%) SHY(-3%) TBT(4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-16.51(-786.49%) | Resistance Level | $2.97 | 5 Day Moving Average | $2.54(-5.31%) | 10 Day Moving Average | $2.68(-10.26%) | 20 Day Moving Average | $2.97(-19.02%) | To recent high | -34.1% | To recent low | 0% | Market Cap | $199m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |